SESEN BIO, INC.

CAMBRIDGE, MA How do I update this listing?

Sesen Bio is based out of Cambridge. Eleven Biotherapeutics Inc provides pharmaceuticals products. The company designs, develops protein-based medicines to treat inflammatory conditions and coagulation disorders. Eleven Biotherapeutics serves pharmaceutical industry throughout the United States.Whalewisdom has at least 109 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2018-04-05. The notice included securities offered of Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security

Create Alert

Contact Info

sesen bio, inc.
245 FIRST STREET
CAMBRIDGE MA    02142

Business Phone: 617-444-8550
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2018-04-05 D BIOTECHNOLOGY Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 996,016 996,016 0
2016-09-28 D BIOTECHNOLOGY Equity 13,525,262 13,525,262 0
2014-12-05 D BIOTECHNOLOGY Equity,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 20,000,010 20,000,010 0
2010-10-13 D/A BIOTECHNOLOGY Equity,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 35,000,000 8,750,000 26,250,000
2010-02-24 D BIOTECHNOLOGY Equity,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 35,000,000 4,500,000 30,500,000
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
ABBIE C. CELNIKER subscription required
    DIRECTOR
ABBIE C. CELNIKER, PH.D. subscription required
    EXECUTIVE OFFICER DIRECTOR
ARTHUR P. DECILLIS subscription required
    EXECUTIVE OFFICER
BARRY J. GERTZ subscription required
    DIRECTOR
CARY PFEFFER subscription required
    EXECUTIVE OFFICER DIRECTOR
DANIEL S. LYNCH subscription required
    DIRECTOR
DAVID M BERRY subscription required
    DIRECTOR
ERIC S. FURFINE subscription required
    EXECUTIVE OFFICER
GREGORY D. PERRY subscription required
    EXECUTIVE OFFICER
JANE V. HENDERSON subscription required
    DIRECTOR
JAY S. DUKER subscription required
    DIRECTOR
JOHN MCCABE subscription required
    EXECUTIVE OFFICER
KAREN L. TURBRIDY subscription required
    EXECUTIVE OFFICER
KIM C. DRAPKIN subscription required
    EXECUTIVE OFFICER
LESLIE DAN subscription required
    DIRECTOR
MARK LEVIN subscription required
    EXECUTIVE OFFICER DIRECTOR
NOUBAR B AFEYAN subscription required
    DIRECTOR
PAUL CHANEY subscription required
    DIRECTOR
RICHARD F. FITZGERALD subscription required
    EXECUTIVE OFFICER
STEPHEN HURLY subscription required
    EXECUTIVE OFFICER DIRECTOR
WENDY L. DIXON subscription required
    DIRECTOR

Elevate your investments